ECSP972049A - Derivados de lactama - Google Patents
Derivados de lactamaInfo
- Publication number
- ECSP972049A ECSP972049A ECSP972049A ECSP972049A EC SP972049 A ECSP972049 A EC SP972049A EC SP972049 A ECSP972049 A EC SP972049A EC SP972049 A ECSP972049 A EC SP972049A
- Authority
- EC
- Ecuador
- Prior art keywords
- derivatives
- lactama
- antagonists
- present
- agonists
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
- 102000035038 5-HT1 receptors Human genes 0.000 abstract 1
- 108091005478 5-HT1 receptors Proteins 0.000 abstract 1
- 102000017911 HTR1A Human genes 0.000 abstract 1
- 101150015707 HTR1A gene Proteins 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003951 lactams Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 229940076279 serotonin Drugs 0.000 abstract 1
- 239000003521 serotonin 5-HT1 receptor agonist Substances 0.000 abstract 1
- 239000002868 serotonin 5-HT1 receptor antagonist Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a derivados de lactama, a procedimientos y a intermedios para su preparación, a composiciones farmacéuticas que los contienen y a su uso en medicina. Los compuestos de la presente invención incluyen agonistas y antagonistas selectivos de receptores de serotonina 1(5-HT 1), específicamente, de uno o de los dos receptores 5-HT1A y 5-HT1). Son útiles en el tratamiento o prevención de la migraña, depresión y otros transtornos para los que están indicados los agonistas o antagonistas de 5-HT1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972049 ECSP972049A (es) | 1997-03-05 | 1997-03-05 | Derivados de lactama |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972049 ECSP972049A (es) | 1997-03-05 | 1997-03-05 | Derivados de lactama |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972049A true ECSP972049A (es) | 1998-02-13 |
Family
ID=42042882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972049 ECSP972049A (es) | 1997-03-05 | 1997-03-05 | Derivados de lactama |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972049A (es) |
-
1997
- 1997-03-05 EC ECSP972049 patent/ECSP972049A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT199700107A (es) | Lactamas e imidas heterociclicas de aralquilo y araquilideno | |
| UA39168C2 (uk) | Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі | |
| BG106142A (en) | Glucocorticoid receptor modulators | |
| BG101806A (bg) | Индолови производни като антагонисти на 5-нт рецептори | |
| NO20003550L (no) | Farmasøytiske sammensetninger og anvendelse herav | |
| DK0760811T3 (da) | Imidazolderivater som histaminreceptor H3-modulatorer | |
| ECSP941122A (es) | Derivados de 5-arilindoles | |
| ATE172723T1 (de) | Tryptamin analoga, ihre herstellung und anwendung als 5-ht1-artige rezeptoren oder 5-ht2 rezeptor agonisten | |
| DK0687251T3 (da) | 1,3-dihydroindol-2-on-derivater, der er substitueret i 3-stillingen med en nitrogengruppe, til anvendelse som vasopressin- og/eller ocytocin-agonister og/eller -antagonister | |
| DE69532162D1 (de) | Cannabinoid-rezeptor-antagonisten | |
| CA2360313A1 (en) | Glucocorticoid receptor modulators | |
| SE9702651D0 (sv) | Novel compounds | |
| BR0015540A (pt) | Antagonistas do receptor de adenosina e métodos de preparação e uso dos mesmos | |
| MX9304595A (es) | Derivados de 1,2,4-triazola substituidos en 4 | |
| AR015446A1 (es) | Antagonistas de receptores de vitronectina, composicion farmaceutica que los contiene, procedimiento para su preparacion, su uso para la elaboracion de unmedicamento y compuestos intermediarios | |
| AR024840A1 (es) | Compuestos de 5ht1 para terapia antidepresiva; composiciones farmaceuticas y su uso en la preparacion de medicamentos. | |
| BR0015172A (pt) | Nova combinação compreendendo um agonista adreno receptor de beta 2 (beta 2) e um antagonista receptor de leucotrieno | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| SE9702002D0 (sv) | Novel compounds | |
| DE69819742D1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
| FR2690847B1 (fr) | Compositions a activite agoniste des recepteurs analogues a 5ht1 selective. | |
| BR0011680A (pt) | Agonistas receptores de somatostatina neuromedina b, seu uso e composição farmacêutica compreendendo os mesmos | |
| ECSP972049A (es) | Derivados de lactama | |
| Millan et al. | Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors | |
| ITTO930661A1 (it) | Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico. |